CORT Competitors
Corcept Therapeutics Incorporated
$117.19
+$0.74(+0.64%)
40
Overall
25
Value
41
Tech
55
Quality
Market Cap
$12.59B
Volume
300.05K
52W Range
$28.66 - $126.38
Target Price
$139.67
CORT competitors: JNJ, BMY, NVS, LLY, PFE. Corcept Therapeutics Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
CORT Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| JNJ Johnson & Johnson | $259.36 | $611.61B | $11.12 | 2.04% | 56 |
| BMY Bristol-Myers Squibb Company | $61.68 | $125.99B | $6.56 | 4.09% | 57 |
| NVS Novartis AG | $153.64 | $293.17B | $8.91 | 3.11% | 73 |
| LLY Eli Lilly and Company | $1283.66 | $1.21T | $33.56 | 0.52% | 60 |
| PFE Pfizer Inc. | $30.11 | $171.62B | $2.95 | 5.71% | 70 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CORT | $117.19 | +0.6% | 300.05K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Corcept Therapeutics Incorporated Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW